{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:21:15Z","timestamp":1790724075179,"version":"4.1.0"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"NIH","award":["R01 NS083845"],"award-info":[{"award-number":["R01 NS083845"]}]},{"name":"NIH","award":["R01 NS133243"],"award-info":[{"award-number":["R01 NS133243"]}]},{"name":"Gift from Lexa\/Nordstjernan establishing the Karolinska Harvard Collaboration"},{"name":"Ellison Foundation of Boston"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Metab Health Dis"],"DOI":"10.1038\/s44324-026-00110-8","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T11:01:01Z","timestamp":1776164461000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Lipid membrane remodeling by myristic acid treatment reverses Parkinson\u2019s disease \u03b1-synuclein phenotypes in patient neurons"],"prefix":"10.1038","volume":"4","author":[{"given":"Julian Avila","family":"Pacheco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gleidia","family":"Sauli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Fonseca-Ornelas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haley","family":"Cirka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepa","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Hazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Jeanfavre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro H.","family":"Vendramini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina R.","family":"Muratore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clary B.","family":"Clish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Selkoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saranna","family":"Fanning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"key":"110_CR1","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/s41593-019-0423-2","volume":"22","author":"SH Shahmoradian","year":"2019","unstructured":"Shahmoradian, S. H. et al. Lewy pathology in Parkinson\u2019s disease consists of crowded organelles and lipid membranes. Nat. Neurosci. 22, 1099\u20131109 (2019).","journal-title":"Nat. Neurosci."},{"key":"110_CR2","doi-asserted-by":"crossref","unstructured":"Moors, T. E. et al. The subcellular arrangement of alpha-synuclein proteoforms in the Parkinson\u2019s disease brain as revealed by multicolor STED microscopy. Acta Neuropathol. 142, 423\u2013448 (2021).","DOI":"10.1007\/s00401-021-02329-9"},{"key":"110_CR3","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1074\/jbc.REV118.006493","volume":"294","author":"D Snead","year":"2019","unstructured":"Snead, D. & Eliezer, D. Intrinsically disordered proteins in synaptic vesicle trafficking and release. J. Biol. Chem. 294, 3325\u20133342 (2019).","journal-title":"J. Biol. Chem."},{"key":"110_CR4","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3389\/fnins.2018.00080","volume":"12","author":"JC Bridi","year":"2018","unstructured":"Bridi, J. C. & Hirth, F. Mechanisms of alpha-synuclein induced synaptopathy in Parkinson\u2019s disease. Front. Neurosci. 12, 80 (2018).","journal-title":"Front. Neurosci."},{"key":"110_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2023.114668","volume":"373","author":"GM Runwal","year":"2024","unstructured":"Runwal, G. M. & Edwards, R. H. The role of alpha-synuclein in exocytosis. Exp. Neurol. 373, 114668 (2024).","journal-title":"Exp. Neurol."},{"key":"110_CR6","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.bpj.2011.01.036","volume":"100","author":"H Cui","year":"2011","unstructured":"Cui, H., Lyman, E. & Voth, G. A. Mechanism of membrane curvature sensing by amphipathic helix containing proteins. Biophys. J. 100, 1271\u20131279 (2011).","journal-title":"Biophys. J."},{"key":"110_CR7","doi-asserted-by":"publisher","first-page":"21966","DOI":"10.1074\/jbc.M401076200","volume":"279","author":"B Nuscher","year":"2004","unstructured":"Nuscher, B. et al. Alpha-synuclein has a high affinity for packing defects in a bilayer membrane: a thermodynamics study. J. Biol. Chem. 279, 21966\u201321975 (2004).","journal-title":"J. Biol. Chem."},{"key":"110_CR8","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1083\/jcb.201011118","volume":"194","author":"IM Pranke","year":"2011","unstructured":"Pranke, I. M. et al. Alpha-synuclein and ALPS motifs are membrane curvature sensors whose contrasting chemistry mediates selective vesicle binding. J. Cell Biol. 194, 89\u2013103 (2011).","journal-title":"J. Cell Biol."},{"key":"110_CR9","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/j.jmb.2007.11.051","volume":"375","author":"M Stockl","year":"2008","unstructured":"Stockl, M., Fischer, P., Wanker, E. & Herrmann, A. Alpha-synuclein selectively binds to anionic phospholipids embedded in liquid-disordered domains. J. Mol. Biol. 375, 1394\u20131404 (2008).","journal-title":"J. Mol. Biol."},{"key":"110_CR10","doi-asserted-by":"publisher","first-page":"41958","DOI":"10.1074\/jbc.M105022200","volume":"276","author":"RJ Perrin","year":"2001","unstructured":"Perrin, R. J., Woods, W. S., Clayton, D. F. & George, J. M. Exposure to long chain polyunsaturated fatty acids triggers rapid multimerization of synucleins. J. Biol. Chem. 276, 41958\u201341962 (2001).","journal-title":"J. Biol. Chem."},{"key":"110_CR11","doi-asserted-by":"publisher","first-page":"9799","DOI":"10.1074\/jbc.RA118.006551","volume":"294","author":"M Rovere","year":"2019","unstructured":"Rovere, M. et al. E46K-like alpha-synuclein mutants increase lipid interactions and disrupt membrane selectivity. J. Biol. Chem. 294, 9799\u20139812 (2019).","journal-title":"J. Biol. Chem."},{"key":"110_CR12","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0166-2236(97)01213-7","volume":"21","author":"DF Clayton","year":"1998","unstructured":"Clayton, D. F. & George, J. M. The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration, and disease. Trends Neurosci. 21, 249\u2013254 (1998).","journal-title":"Trends Neurosci."},{"key":"110_CR13","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1016\/j.bpj.2010.07.056","volume":"99","author":"ER Middleton","year":"2010","unstructured":"Middleton, E. R. & Rhoades, E. Effects of curvature and composition on alpha-synuclein binding to lipid vesicles. Biophys. J. 99, 2279\u20132288 (2010).","journal-title":"Biophys. J."},{"key":"110_CR14","doi-asserted-by":"publisher","first-page":"42603","DOI":"10.1074\/jbc.M111.271130","volume":"286","author":"MB Jensen","year":"2011","unstructured":"Jensen, M. B. et al. Membrane curvature sensing by amphipathic helices: a single liposome study using alpha-synuclein and annexin B12. J. Biol. Chem. 286, 42603\u201342614 (2011).","journal-title":"J. Biol. Chem."},{"key":"110_CR15","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1074\/jbc.M112.418871","volume":"288","author":"CH Westphal","year":"2013","unstructured":"Westphal, C. H. & Chandra, S. S. Monomeric synucleins generate membrane curvature. J. Biol. Chem. 288, 1829\u20131840 (2013).","journal-title":"J. Biol. Chem."},{"key":"110_CR16","doi-asserted-by":"publisher","first-page":"49874","DOI":"10.1074\/jbc.M309127200","volume":"278","author":"R Sharon","year":"2003","unstructured":"Sharon, R., Bar-Joseph, I., Mirick, G. E., Serhan, C. N. & Selkoe, D. J. Altered fatty acid composition of dopaminergic neurons expressing alpha-synuclein and human brains with alpha-synucleinopathies. J. Biol. Chem. 278, 49874\u201349881 (2003).","journal-title":"J. Biol. Chem."},{"key":"110_CR17","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.bbamem.2016.11.001","volume":"1859","author":"J Kurniawan","year":"2017","unstructured":"Kurniawan, J., Suga, K. & Kuhl, T. L. Interaction forces and membrane charge tunability: oleic acid containing membranes in different pH conditions. Biochim. Biophys. Acta Biomembr. 1859, 211\u2013217 (2017).","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"110_CR18","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.molcel.2018.11.028","volume":"73","author":"S Fanning","year":"2018","unstructured":"Fanning, S. et al. Lipidomic analysis of alpha-synuclein neurotoxicity identifies stearoyl CoA desaturase as a target for Parkinson treatment. Mol. Cell 73, 1001\u20131014.e1008 (2018).","journal-title":"Mol. Cell"},{"key":"110_CR19","doi-asserted-by":"publisher","first-page":"20760","DOI":"10.1073\/pnas.1903216116","volume":"116","author":"T Imberdis","year":"2019","unstructured":"Imberdis, T. et al. Cell models of lipid-rich alpha-synuclein aggregation validate known modifiers of alpha-synuclein biology and identify stearoyl-CoA desaturase. Proc. Natl. Acad. Sci. USA 116, 20760\u201320769 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"110_CR20","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41531-022-00335-6","volume":"8","author":"S Fanning","year":"2022","unstructured":"Fanning, S. et al. Lipase regulation of cellular fatty acid homeostasis as a Parkinson\u2019s disease therapeutic strategy. npj Parkinsons Dis. 8, 74 (2022).","journal-title":"npj Parkinsons Dis."},{"key":"110_CR21","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1007\/s13311-022-01199-7","volume":"19","author":"S Nuber","year":"2022","unstructured":"Nuber, S. et al. A brain-penetrant stearoyl-CoA desaturase inhibitor reverses alpha-synuclein toxicity. Neurotherapeutics 19, 1018\u20131036 (2022).","journal-title":"Neurotherapeutics"},{"key":"110_CR22","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/ana.25920","volume":"89","author":"S Nuber","year":"2021","unstructured":"Nuber, S. et al. A stearoyl-coenzyme a desaturase inhibitor prevents multiple Parkinson disease phenotypes in alpha-synuclein mice. Ann. Neurol. 89, 74\u201390 (2021).","journal-title":"Ann. Neurol."},{"key":"110_CR23","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1016\/j.celrep.2018.11.028","volume":"25","author":"BM Vincent","year":"2018","unstructured":"Vincent, B. M. et al. Inhibiting stearoyl-CoA desaturase ameliorates alpha-synuclein cytotoxicity. Cell Rep. 25, 2742\u20132754.e2731 (2018).","journal-title":"Cell Rep."},{"key":"110_CR24","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3389\/fnagi.2019.00207","volume":"11","author":"M Maulik","year":"2019","unstructured":"Maulik, M. et al. Genetic silencing of fatty acid desaturases modulates alpha-synuclein toxicity and neuronal loss in Parkinson-like models of C. elegans. Front. Aging Neurosci. 11, 207 (2019).","journal-title":"Front. Aging Neurosci."},{"key":"110_CR25","doi-asserted-by":"publisher","unstructured":"Terry-Kantor, E. et al. Rapid alpha-synuclein toxicity in a neural cell model and its rescue by a stearoyl-CoA desaturase inhibitor. Int. J. Mol. Sci. 21, https:\/\/doi.org\/10.3390\/ijms21155193 (2020).","DOI":"10.3390\/ijms21155193"},{"key":"110_CR26","doi-asserted-by":"crossref","unstructured":"Adom, M. A. et al. Reducing the lipase LIPE in mutant alpha-synuclein mice improves Parkinson-like deficits and reveals sex differences in fatty acid metabolism. Neurobiol. Dos. 199, 106593, (2024).","DOI":"10.1016\/j.nbd.2024.106593"},{"key":"110_CR27","doi-asserted-by":"publisher","first-page":"9443","DOI":"10.1074\/jbc.273.16.9443","volume":"273","author":"WS Davidson","year":"1998","unstructured":"Davidson, W. S., Jonas, A., Clayton, D. F. & George, J. M. Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes. J. Biol. Chem. 273, 9443\u20139449 (1998).","journal-title":"J. Biol. Chem."},{"key":"110_CR28","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nature10324","volume":"477","author":"T Bartels","year":"2011","unstructured":"Bartels, T., Choi, J. G. & Selkoe, D. J. alpha-synuclein occurs physiologically as a helically folded tetramer that resists aggregation. Nature 477, 107\u2013110 (2011).","journal-title":"Nature"},{"key":"110_CR29","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3233\/JPD-150642","volume":"5","author":"J Burre","year":"2015","unstructured":"Burre, J. The synaptic function of alpha-synuclein. J. Parkinsons Dis. 5, 699\u2013713 (2015).","journal-title":"J. Parkinsons Dis."},{"key":"110_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8314","volume":"6","author":"U Dettmer","year":"2015","unstructured":"Dettmer, U. et al. Parkinson-causing alpha-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation. Nat. Commun. 6, 7314 (2015).","journal-title":"Nat. Commun."},{"key":"110_CR31","doi-asserted-by":"publisher","first-page":"9596","DOI":"10.1073\/pnas.1505953112","volume":"112","author":"U Dettmer","year":"2015","unstructured":"Dettmer, U., Newman, A. J., von Saucken, V. E., Bartels, T. & Selkoe, D. KTKEGV repeat motifs are key mediators of normal alpha-synuclein tetramerization: their mutation causes excess monomers and neurotoxicity. Proc. Natl. Acad. Sci. USA 112, 9596\u20139601 (2015).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"110_CR32","doi-asserted-by":"publisher","first-page":"3466","DOI":"10.1093\/hmg\/ddx227","volume":"26","author":"U Dettmer","year":"2017","unstructured":"Dettmer, U. et al. Loss of native alpha-synuclein multimerization by strategically mutating its amphipathic helix causes abnormal vesicle interactions in neuronal cells. Hum. Mol. Genet. 26, 3466\u20133481 (2017).","journal-title":"Hum. Mol. Genet."},{"key":"110_CR33","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1159\/000355516","volume":"13","author":"D Selkoe","year":"2014","unstructured":"Selkoe, D. et al. Defining the native state of alpha-synuclein. Neurodegener. Dis. 13, 114\u2013117 (2014).","journal-title":"Neurodegener. Dis."},{"key":"110_CR34","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.neuron.2018.09.014","volume":"100","author":"S Nuber","year":"2018","unstructured":"Nuber, S. et al. Abrogating native alpha-synuclein tetramers in mice causes a L-DOPA-responsive motor syndrome closely resembling Parkinson\u2019s disease. Neuron 100, 75\u201390.e75 (2018).","journal-title":"Neuron"},{"key":"110_CR35","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41531-022-00380-1","volume":"8","author":"L Fonseca-Ornelas","year":"2022","unstructured":"Fonseca-Ornelas, L. et al. Parkinson-causing mutations in LRRK2 impair the physiological tetramerization of endogenous alpha-synuclein in human neurons. npj Parkinsons Dis. 8, 118 (2022).","journal-title":"npj Parkinsons Dis."},{"key":"110_CR36","doi-asserted-by":"publisher","unstructured":"Glajch, K. E. et al. Wild-type GBA1 increases the alpha-synuclein tetramer-monomer ratio, reduces lipid-rich aggregates, and attenuates motor and cognitive deficits in mice. Proc. Natl. Acad. Sci. USA 118, https:\/\/doi.org\/10.1073\/pnas.2103425118 (2021).","DOI":"10.1073\/pnas.2103425118"},{"key":"110_CR37","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1073\/pnas.1700465115","volume":"115","author":"S Kim","year":"2018","unstructured":"Kim, S. et al. GBA1 deficiency negatively affects physiological alpha-synuclein tetramers and related multimers. Proc. Natl. Acad. Sci. USA 115, 798\u2013803 (2018).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"110_CR38","doi-asserted-by":"publisher","first-page":"7628","DOI":"10.1523\/JNEUROSCI.0313-19.2019","volume":"39","author":"MM Rajsombath","year":"2019","unstructured":"Rajsombath, M. M., Nam, A. Y., Ericsson, M. & Nuber, S. Female sex and brain-selective estrogen benefit alpha-synuclein tetramerization and the PD-like motor syndrome in 3k transgenic mice. J. Neurosci. 39, 7628\u20137640 (2019).","journal-title":"J. Neurosci."},{"key":"110_CR39","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1021\/bi901723p","volume":"49","author":"CR Bodner","year":"2010","unstructured":"Bodner, C. R., Maltsev, A. S., Dobson, C. M. & Bax, A. Differential phospholipid binding of alpha-synuclein variants implicated in Parkinson\u2019s disease revealed by solution NMR spectroscopy. Biochemistry 49, 862\u2013871 (2010).","journal-title":"Biochemistry"},{"key":"110_CR40","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.febslet.2004.09.038","volume":"576","author":"W Choi","year":"2004","unstructured":"Choi, W. et al. Mutation E46K increases phospholipid binding and assembly into filaments of human alpha-synuclein. FEBS Lett. 576, 363\u2013368 (2004).","journal-title":"FEBS Lett."},{"key":"110_CR41","doi-asserted-by":"publisher","DOI":"10.5402\/2011\/521847","volume":"2011","author":"M Fiske","year":"2011","unstructured":"Fiske, M. et al. Familial parkinson\u2019s disease mutant E46K alpha-synuclein localizes to membranous structures, forms aggregates, and induces toxicity in yeast models. ISRN Neurol. 2011, 521847 (2011).","journal-title":"ISRN Neurol."},{"key":"110_CR42","doi-asserted-by":"publisher","first-page":"7177","DOI":"10.1074\/jbc.M808895200","volume":"284","author":"JD Perlmutter","year":"2009","unstructured":"Perlmutter, J. D., Braun, A. R. & Sachs, J. N. Curvature dynamics of alpha-synuclein familial Parkinson disease mutants: molecular simulations of the micelle- and bilayer-bound forms. J. Biol. Chem. 284, 7177\u20137189 (2009).","journal-title":"J. Biol. Chem."},{"key":"110_CR43","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1021\/cn500332w","volume":"6","author":"IF Tsigelny","year":"2015","unstructured":"Tsigelny, I. F. et al. Molecular determinants of alpha-synuclein mutants\u2019 oligomerization and membrane interactions. ACS Chem. Neurosci. 6, 403\u2013416 (2015).","journal-title":"ACS Chem. Neurosci."},{"key":"110_CR44","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1523\/JNEUROSCI.1881-21.2022","volume":"42","author":"A Tripathi","year":"2022","unstructured":"Tripathi, A. et al. Pathogenic mechanisms of cytosolic and membrane-enriched alpha-synuclein converge on fatty acid homeostasis. J. Neurosci. 42, 2116\u20132130 (2022).","journal-title":"J. Neurosci."},{"key":"110_CR45","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1007\/s00125-017-4366-4","volume":"60","author":"T Takato","year":"2017","unstructured":"Takato, T., Iwata, K., Murakami, C., Wada, Y. & Sakane, F. Chronic administration of myristic acid improves hyperglycaemia in the Nagoya-Shibata-Yasuda mouse model of congenital type 2 diabetes. Diabetologia 60, 2076\u20132083 (2017).","journal-title":"Diabetologia"},{"key":"110_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.907526","volume":"9","author":"Q Shang","year":"2022","unstructured":"Shang, Q. et al. Myristic acid alleviates hippocampal aging correlated with GABAergic signaling. Front. Nutr. 9, 907526 (2022).","journal-title":"Front. Nutr."},{"key":"110_CR47","doi-asserted-by":"publisher","unstructured":"Mett, J. et al. Medium-chain length fatty acids enhance abeta degradation by affecting insulin-degrading enzyme. Cells 10, https:\/\/doi.org\/10.3390\/cells10112941 (2021).","DOI":"10.3390\/cells10112941"},{"key":"110_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36332-3","volume":"14","author":"M Jia","year":"2023","unstructured":"Jia, M. et al. Myristic acid as a checkpoint to regulate STING-dependent autophagy and interferon responses by promoting N-myristoylation. Nat. Commun. 14, 660 (2023).","journal-title":"Nat. Commun."},{"key":"110_CR49","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.nbd.2017.07.007","volume":"106","author":"TJ Collier","year":"2017","unstructured":"Collier, T. J. et al. Nortriptyline inhibits aggregation and neurotoxicity of alpha-synuclein by enhancing reconfiguration of the monomeric form. Neurobiol. Dis. 106, 191\u2013204 (2017).","journal-title":"Neurobiol. Dis."},{"key":"110_CR50","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/0896-6273(95)90040-3","volume":"15","author":"JM George","year":"1995","unstructured":"George, J. M., Jin, H., Woods, W. S. & Clayton, D. F. Characterization of a novel protein regulated during the critical period for song learning in the zebra finch. Neuron 15, 361\u2013372 (1995).","journal-title":"Neuron"},{"key":"110_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03111-4","volume":"9","author":"J Lautenschlager","year":"2018","unstructured":"Lautenschlager, J. et al. C-terminal calcium binding of alpha-synuclein modulates synaptic vesicle interaction. Nat. Commun. 9, 712 (2018).","journal-title":"Nat. Commun."},{"key":"110_CR52","doi-asserted-by":"publisher","first-page":"E4274","DOI":"10.1073\/pnas.1416598111","volume":"111","author":"J Burre","year":"2014","unstructured":"Burre, J., Sharma, M. & Sudhof, T. C. Alpha-synuclein assembles into higher-order multimers upon membrane binding to promote SNARE complex formation. Proc. Natl. Acad. Sci. USA 111, E4274\u2013E4283 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"110_CR53","doi-asserted-by":"publisher","first-page":"15227","DOI":"10.1523\/JNEUROSCI.3545-12.2012","volume":"32","author":"J Burre","year":"2012","unstructured":"Burre, J., Sharma, M. & Sudhof, T. C. Systematic mutagenesis of alpha-synuclein reveals distinct sequence requirements for physiological and pathological activities. J. Neurosci. 32, 15227\u201315242 (2012).","journal-title":"J. Neurosci."},{"key":"110_CR54","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1126\/science.1195227","volume":"329","author":"J Burre","year":"2010","unstructured":"Burre, J. et al. Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro. Science 329, 1663\u20131667 (2010).","journal-title":"Science"},{"key":"110_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-90503-0","volume":"11","author":"G Yoo","year":"2021","unstructured":"Yoo, G., Yeou, S., Son, J. B., Shin, Y. K. & Lee, N. K. Cooperative inhibition of SNARE-mediated vesicle fusion by alpha-synuclein monomers and oligomers. Sci. Rep. 11, 10955 (2021).","journal-title":"Sci. Rep."},{"key":"110_CR56","doi-asserted-by":"publisher","first-page":"18977","DOI":"10.1073\/pnas.2006291117","volume":"117","author":"U Kaur","year":"2020","unstructured":"Kaur, U. & Lee, J. C. Unroofing site-specific alpha-synuclein-lipid interactions at the plasma membrane. Proc. Natl. Acad. Sci. USA 117, 18977\u201318983 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"110_CR57","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1042\/BCJ20170200","volume":"474","author":"X Lou","year":"2017","unstructured":"Lou, X., Kim, J., Hawk, B. J. & Shin, Y. K. Alpha-synuclein may cross-bridge v-SNARE and acidic phospholipids to facilitate SNARE-dependent vesicle docking. Biochem. J. 474, 2039\u20132049 (2017).","journal-title":"Biochem. J."},{"key":"110_CR58","doi-asserted-by":"publisher","first-page":"3889","DOI":"10.1021\/bi5002536","volume":"53","author":"Y Lai","year":"2014","unstructured":"Lai, Y. et al. Nonaggregated alpha-synuclein influences SNARE-dependent vesicle docking via membrane binding. Biochemistry 53, 3889\u20133896 (2014).","journal-title":"Biochemistry"},{"key":"110_CR59","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.00592","volume":"2","author":"J Diao","year":"2013","unstructured":"Diao, J. et al. Native alpha-synuclein induces clustering of synaptic-vesicle mimics via binding to phospholipids and synaptobrevin-2\/VAMP2. eLife 2, e00592 (2013).","journal-title":"eLife"},{"key":"110_CR60","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1021\/bi4002369","volume":"52","author":"DC DeWitt","year":"2013","unstructured":"DeWitt, D. C. & Rhoades, E. Alpha-synuclein can inhibit SNARE-mediated vesicle fusion through direct interactions with lipid bilayers. Biochemistry 52, 2385\u20132387 (2013).","journal-title":"Biochemistry"},{"key":"110_CR61","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.neuron.2009.12.023","volume":"65","author":"VM Nemani","year":"2010","unstructured":"Nemani, V. M. et al. Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis. Neuron 65, 66\u201379 (2010).","journal-title":"Neuron"},{"key":"110_CR62","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/jnc.14810","volume":"150","author":"D Sulzer","year":"2019","unstructured":"Sulzer, D. & Edwards, R. H. The physiological role of alpha-synuclein and its relationship to Parkinson\u2019s disease. J. Neurochem. 150, 475\u2013486 (2019).","journal-title":"J. Neurochem."},{"key":"110_CR63","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/nn.4529","volume":"20","author":"T Logan","year":"2017","unstructured":"Logan, T., Bendor, J., Toupin, C., Thorn, K. & Edwards, R. H. Alpha-synuclein promotes dilation of the exocytotic fusion pore. Nat. Neurosci. 20, 681\u2013689 (2017).","journal-title":"Nat. Neurosci."},{"key":"110_CR64","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1146\/annurev-pathol-031920-092547","volume":"16","author":"G Runwal","year":"2021","unstructured":"Runwal, G. & Edwards, R. H. The membrane interactions of synuclein: physiology and pathology. Annu. Rev. Pathol. 16, 465\u2013485 (2021).","journal-title":"Annu. Rev. Pathol."},{"key":"110_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21027-4","volume":"12","author":"WK Man","year":"2021","unstructured":"Man, W. K. et al. The docking of synaptic vesicles on the presynaptic membrane induced by alpha-synuclein is modulated by lipid composition. Nat. Commun. 12, 927 (2021).","journal-title":"Nat. Commun."},{"key":"110_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109333","volume":"36","author":"L Fonseca-Ornelas","year":"2021","unstructured":"Fonseca-Ornelas, L. et al. Altered conformation of alpha-synuclein drives dysfunction of synaptic vesicles in a synaptosomal model of Parkinson\u2019s disease. Cell Rep. 36, 109333 (2021).","journal-title":"Cell Rep."},{"key":"110_CR67","doi-asserted-by":"publisher","first-page":"11116","DOI":"10.1073\/pnas.1903054116","volume":"116","author":"M Atias","year":"2019","unstructured":"Atias, M. et al. Synapsins regulate alpha-synuclein functions. Proc. Natl. Acad. Sci. USA 116, 11116\u201311118 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"110_CR68","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3389\/fncel.2017.00388","volume":"11","author":"AT Medeiros","year":"2017","unstructured":"Medeiros, A. T., Soll, L. G., Tessari, I., Bubacco, L. & Morgan, J. R. Alpha-synuclein dimers impair vesicle fission during clathrin-mediated synaptic vesicle recycling. Front. Cell Neurosci. 11, 388 (2017).","journal-title":"Front. Cell Neurosci."},{"key":"110_CR69","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.celrep.2016.12.023","volume":"18","author":"KJ Vargas","year":"2017","unstructured":"Vargas, K. J. et al. Synucleins have multiple effects on presynaptic architecture. Cell Rep. 18, 161\u2013173 (2017).","journal-title":"Cell Rep."},{"key":"110_CR70","doi-asserted-by":"publisher","first-page":"10913","DOI":"10.1523\/JNEUROSCI.2922-05.2005","volume":"25","author":"DL Fortin","year":"2005","unstructured":"Fortin, D. L. et al. Neural activity controls the synaptic accumulation of alpha-synuclein. J. Neurosci. 25, 10913\u201310921 (2005).","journal-title":"J. Neurosci."},{"key":"110_CR71","doi-asserted-by":"publisher","first-page":"6715","DOI":"10.1523\/JNEUROSCI.1594-04.2004","volume":"24","author":"DL Fortin","year":"2004","unstructured":"Fortin, D. L. et al. Lipid rafts mediate the synaptic localization of alpha-synuclein. J. Neurosci. 24, 6715\u20136723 (2004).","journal-title":"J. Neurosci."},{"key":"110_CR72","doi-asserted-by":"publisher","first-page":"11113","DOI":"10.1073\/pnas.1903049116","volume":"116","author":"J Sun","year":"2019","unstructured":"Sun, J. et al. Functional cooperation of alpha-synuclein and VAMP2 in synaptic vesicle recycling. Proc. Natl. Acad. Sci. USA 116, 11113\u201311115 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"110_CR73","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1073\/pnas.1200575109","volume":"109","author":"M Lundblad","year":"2012","unstructured":"Lundblad, M., Decressac, M., Mattsson, B. & Bjorklund, A. Impaired neurotransmission caused by overexpression of alpha-synuclein in nigral dopamine neurons. Proc. Natl. Acad. Sci. USA 109, 3213\u20133219 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"110_CR74","volume":"22","author":"H Yamada","year":"2020","unstructured":"Yamada, H., Hoshino, F., Lu, Q. & Sakane, F. Cellular phosphatidic acid sensor, alpha-synuclein N-terminal domain, detects endogenous phosphatidic acid in macrophagic phagosomes and neuronal growth cones. Biochem. Biophys. Rep. 22, 100769 (2020).","journal-title":"Biochem. Biophys. Rep."},{"key":"110_CR75","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3389\/fncel.2019.00175","volume":"13","author":"NP Alza","year":"2019","unstructured":"Alza, N. P., Iglesias Gonzalez, P. A., Conde, M. A., Uranga, R. M. & Salvador, G. A. Lipids at the crossroad of alpha-synuclein function and dysfunction: biological and pathological implications. Front. Cell Neurosci. 13, 175 (2019).","journal-title":"Front. Cell Neurosci."},{"key":"110_CR76","doi-asserted-by":"publisher","first-page":"34393","DOI":"10.1074\/jbc.M004851200","volume":"275","author":"RJ Perrin","year":"2000","unstructured":"Perrin, R. J., Woods, W. S., Clayton, D. F. & George, J. M. Interaction of human alpha-synuclein and Parkinson\u2019s disease variants with phospholipids structural analysis using site-directed mutagenesis. J. Biol. Chem. 275, 34393\u201334398 (2000).","journal-title":"J. Biol. Chem."},{"key":"110_CR77","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1002\/1873-3468.12592","volume":"591","author":"S Mizuno","year":"2017","unstructured":"Mizuno, S. et al. Dioleoyl-phosphatidic acid selectively binds to alpha-synuclein and strongly induces its aggregation. FEBS Lett. 591, 784\u2013791 (2017).","journal-title":"FEBS Lett."},{"key":"110_CR78","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s12013-017-0792-7","volume":"75","author":"WK Subczynski","year":"2017","unstructured":"Subczynski, W. K., Pasenkiewicz-Gierula, M., Widomska, J., Mainali, L. & Raguz, M. High cholesterol\/low cholesterol: effects in biological membranes: a review. Cell Biochem. Biophys. 75, 369\u2013385 (2017).","journal-title":"Cell Biochem. Biophys."},{"key":"110_CR79","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1093\/jb\/mvs105","volume":"152","author":"A Kihara","year":"2012","unstructured":"Kihara, A. Very long-chain fatty acids: elongation, physiology and related disorders. J. Biochem. 152, 387\u2013395 (2012).","journal-title":"J. Biochem."},{"key":"110_CR80","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1038\/s12276-020-00503-9","volume":"52","author":"DS Jo","year":"2020","unstructured":"Jo, D. S., Park, N. Y. & Cho, D. H. Peroxisome quality control and dysregulated lipid metabolism in neurodegenerative diseases. Exp. Mol. Med. 52, 1486\u20131495 (2020).","journal-title":"Exp. Mol. Med."},{"key":"110_CR81","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1090278","volume":"302","author":"AB Singleton","year":"2003","unstructured":"Singleton, A. B. et al. alpha-synuclein locus triplication causes Parkinson\u2019s disease. Science 302, 841 (2003).","journal-title":"Science"},{"key":"110_CR82","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.parkreldis.2015.06.005","volume":"21","author":"S Olgiati","year":"2015","unstructured":"Olgiati, S. et al. Early-onset parkinsonism caused by alpha-synuclein gene triplication: Clinical and genetic findings in a novel family. Parkinsonism Relat. Disord. 21, 981\u2013986 (2015).","journal-title":"Parkinsonism Relat. Disord."},{"key":"110_CR83","doi-asserted-by":"crossref","unstructured":"Ramalingam, N. & Dettmer, U. Temperature is a key determinant of alpha- and beta-synuclein membrane interactions in neurons. J. Biol. Chem. 296, 100271 (2021).","DOI":"10.1016\/j.jbc.2021.100271"},{"key":"110_CR84","doi-asserted-by":"publisher","first-page":"6371","DOI":"10.1074\/jbc.M112.403311","volume":"288","author":"U Dettmer","year":"2013","unstructured":"Dettmer, U., Newman, A. J., Luth, E. S., Bartels, T. & Selkoe, D. In vivo cross-linking reveals principally oligomeric forms of alpha-synuclein and beta-synuclein in neurons and non-neural cells. J. Biol. Chem. 288, 6371\u20136385 (2013).","journal-title":"J. Biol. Chem."},{"key":"110_CR85","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.conb.2015.07.007","volume":"36","author":"U Dettmer","year":"2016","unstructured":"Dettmer, U., Selkoe, D. & Bartels, T. New insights into cellular alpha-synuclein homeostasis in health and disease. Curr. Opin. Neurobiol. 36, 15\u201322 (2016).","journal-title":"Curr. Opin. Neurobiol."},{"key":"110_CR86","doi-asserted-by":"publisher","unstructured":"Fernandez-Irigoyen, J., Cartas-Cejudo, P., Iruarrizaga-Lejarreta, M. & Santamaria, E. Alteration in the cerebrospinal fluid lipidome in Parkinson\u2019s disease: a post-mortem pilot study. Biomedicines 9, https:\/\/doi.org\/10.3390\/biomedicines9050491 (2021).","DOI":"10.3390\/biomedicines9050491"},{"key":"110_CR87","doi-asserted-by":"publisher","first-page":"e17299","DOI":"10.1371\/journal.pone.0017299","volume":"6","author":"D Cheng","year":"2011","unstructured":"Cheng, D. et al. Lipid pathway alterations in Parkinson\u2019s disease primary visual cortex. PLoS One 6, e17299 (2011).","journal-title":"PLoS One"},{"key":"110_CR88","doi-asserted-by":"publisher","unstructured":"Chiurchiu, V. et al. Lipidomics of bioactive lipids in Alzheimer\u2019s and Parkinson\u2019s diseases: Where are we? Int. J. Mol. Sci. 23, https:\/\/doi.org\/10.3390\/ijms23116235 (2022).","DOI":"10.3390\/ijms23116235"},{"key":"110_CR89","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41531-021-00168-9","volume":"7","author":"H Xicoy","year":"2021","unstructured":"Xicoy, H. et al. Shared genetic etiology between Parkinson\u2019s disease and blood levels of specific lipids. npj Parkinsons Dis. 7, 23 (2021).","journal-title":"npj Parkinsons Dis."},{"key":"110_CR90","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/j.1471-4159.1988.tb02958.x","volume":"50","author":"R Spector","year":"1988","unstructured":"Spector, R. Fatty acid transport through the blood-brain barrier. J. Neurochem. 50, 639\u2013643 (1988).","journal-title":"J. Neurochem."},{"key":"110_CR91","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1007\/s11095-013-1056-x","volume":"30","author":"J Shen","year":"2013","unstructured":"Shen, J. et al. Fatty acid-based strategy for efficient brain targeted gene delivery. Pharm. Res. 30, 2573\u20132583 (2013).","journal-title":"Pharm. Res."},{"key":"110_CR92","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ejpb.2022.02.004","volume":"172","author":"A Brookes","year":"2022","unstructured":"Brookes, A. et al. Is oral lipid-based delivery for drug targeting to the brain feasible? Eur. J. Pharm. Biopharm. 172, 112\u2013122 (2022).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"110_CR93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbalip.2010.09.005","volume":"1811","author":"V Rioux","year":"2011","unstructured":"Rioux, V., Pedrono, F. & Legrand, P. Regulation of mammalian desaturases by myristic acid: N-terminal myristoylation and other modulations. Biochim. Biophys. Acta 1811, 1\u20138 (2011).","journal-title":"Biochim. Biophys. Acta"},{"key":"110_CR94","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1453","volume":"2","author":"MJ Devine","year":"2011","unstructured":"Devine, M. J. et al. Parkinson\u2019s disease induced pluripotent stem cells with triplication of the alpha-synuclein locus. Nat. Commun. 2, 440 (2011).","journal-title":"Nat. Commun."},{"key":"110_CR95","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/ejn.14286","volume":"49","author":"Y Chen","year":"2019","unstructured":"Chen, Y. et al. Engineering synucleinopathy-resistant human dopaminergic neurons by CRISPR-mediated deletion of the SNCA gene. Eur. J. Neurosci. 49, 510\u2013524 (2019).","journal-title":"Eur. J. Neurosci."},{"key":"110_CR96","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nature10202","volume":"476","author":"ZP Pang","year":"2011","unstructured":"Pang, Z. P. et al. Induction of human neuronal cells by defined transcription factors. Nature 476, 220\u2013223 (2011).","journal-title":"Nature"},{"key":"110_CR97","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.neuron.2013.05.029","volume":"78","author":"Y Zhang","year":"2013","unstructured":"Zhang, Y. et al. Rapid single-step induction of functional neurons from human pluripotent stem cells. Neuron 78, 785\u2013798 (2013).","journal-title":"Neuron"},{"key":"110_CR98","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J. R. Stat. Soc. Ser. B Methodol. 57, 289\u2013300 (1995).","journal-title":"J. R. Stat. Soc. Ser. B Methodol."},{"key":"110_CR99","doi-asserted-by":"publisher","first-page":"5449","DOI":"10.1021\/jm0607653","volume":"50","author":"S Ebdrup","year":"2007","unstructured":"Ebdrup, S., Refsgaard, H. H., Fledelius, C. & Jacobsen, P. Synthesis and structure-activity relationship for a novel class of potent and selective carbamate-based inhibitors of hormone selective lipase with acute in vivo antilipolytic effects. J. Med. Chem. 50, 5449\u20135456 (2007).","journal-title":"J. Med. Chem."},{"key":"110_CR100","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s10858-012-9611-z","volume":"52","author":"SG Hyberts","year":"2012","unstructured":"Hyberts, S. G., Milbradt, A. G., Wagner, A. B., Arthanari, H. & Wagner, G. Application of iterative soft thresholding for fast reconstruction of NMR data non-uniformly sampled with multidimensional Poisson Gap scheduling. J. Biomol. NMR 52, 315\u2013327 (2012).","journal-title":"J. Biomol. NMR"},{"key":"110_CR101","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1002\/prot.20449","volume":"59","author":"WF Vranken","year":"2005","unstructured":"Vranken, W. F. et al. The CCPN data model for NMR spectroscopy: development of a software pipeline. Proteins 59, 687\u2013696 (2005).","journal-title":"Proteins"}],"container-title":["npj Metabolic Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44324-026-00110-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44324-026-00110-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44324-026-00110-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T12:03:06Z","timestamp":1776168186000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44324-026-00110-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":101,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["110"],"URL":"https:\/\/doi.org\/10.1038\/s44324-026-00110-8","relation":{},"ISSN":["2948-2828"],"issn-type":[{"value":"2948-2828","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]},"assertion":[{"value":"12 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.J.S. is a director of Prothena Biosciences and an ad hoc consultant to Eisai. S.F. is an ad hoc consultant to Janssen and Congruence Therapeutics.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15"}}